Who the hell is AF anyway?
I mean, what are his credentials that people
should take him as an authority?
He appears to be correct a whole lot of the time
when he bashes a stock (I don't think he ever gives
a recommendation) but, guess what, in the small biotech space
something like 19 out of 20 FAIL! Anybody can look
like a genius with those odds. Show me a company which
he favored and which subsequently succeeded. Anybody?
I don't know if NWBO will succeed but neither does AF.
Science looks solid, initial results look great.
Plenty of experts have gotten behind NWBO AND IMUC
even after IMUCs so-called failure.
The possibilities are fascinating and, my goodness, if
you are a biotech investor you cannot afford to not take at least
a little piece of NWBO. There are very few potentially ground
breaking drugs or therapies in development stage.
Apply the rule of reasonable expectations. Say 20% chance of
success and 80% chance of failure: 80% x $0 stock price
plus 20% x $50 stock price = $10 stock price.
Even at that, worth an investment, particularly as part of
a larger portfolio of similarly-analyzed small biopharmas.
News 
Market Data 
Discover 
AI
